Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
C$12.33
-4.5%
C$12.77
C$8.38
C$19.69
C$221.36M1.229,185 shs23,960 shs
Cronos Group Inc. stock logo
CRON
Cronos Group
$2.01
-2.0%
$1.99
$1.60
$2.54
$775.22M1.031.37 million shs1.78 million shs
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
C$6.05
-2.6%
C$5.91
C$5.09
C$6.45
C$611.96M0.566,777 shs164,416 shs
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
$0.62
+1.6%
$0.46
$0.35
$2.15
$615.27M1.8231.26 million shs28.80 million shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
-4.49%-4.57%-4.57%+3.53%+48.02%
Cronos Group Inc. stock logo
CRON
Cronos Group
-1.95%-3.83%+5.24%+13.56%-17.96%
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
-2.58%-1.31%+1.85%+6.33%+5.40%
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
+1.64%+7.03%+62.09%+38.07%-67.30%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
1.5782 of 5 stars
2.40.00.00.02.11.71.3
Cronos Group Inc. stock logo
CRON
Cronos Group
2.0409 of 5 stars
0.04.00.00.02.60.02.5
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
1.0562 of 5 stars
2.80.00.00.00.01.70.6
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
1.8731 of 5 stars
3.11.00.00.03.10.01.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
2.75
Moderate BuyC$14.7519.63% Upside
Cronos Group Inc. stock logo
CRON
Cronos Group
0.00
N/AN/AN/A
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
3.50
Strong BuyC$7.1518.18% Upside
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
2.25
Hold$1.92208.49% Upside

Current Analyst Ratings Breakdown

Latest CPH, CRON, GUD, and TLRY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/9/2025
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetHold ➝ BuyC$6.50
(Data available from 7/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
C$19.03M11.63C$3.49 per share3.53C$3.96 per share3.11
Cronos Group Inc. stock logo
CRON
Cronos Group
$124.59M6.22$0.00 per share4,405.57$2.90 per share0.69
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
C$348.70M1.75C$1.57 per share3.85C$7.65 per share0.79
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
$210.48M2.97N/AN/A$4.14 per share0.15
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
C$11.41MC$0.9113.62N/A59.92%17.93%7.90%N/A
Cronos Group Inc. stock logo
CRON
Cronos Group
$41.08M$0.1315.4667.00N/A39.69%-0.07%-0.07%8/6/2025 (Estimated)
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
-C$30.73M-C$0.30N/AN/A-8.81%-4.04%0.51%N/A
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
-$244.98M-$1.05N/AN/AN/A-113.85%-7.40%-6.02%7/28/2025 (Estimated)

Latest CPH, CRON, GUD, and TLRY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2025Q2 2025
Cronos Group Inc. stock logo
CRON
Cronos Group
-$0.02N/AN/AN/AN/AN/A
7/28/2025Q4 2025
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
-$0.03N/AN/AN/A$250.41 millionN/A
5/8/2025Q1 2025
Cronos Group Inc. stock logo
CRON
Cronos Group
$0.01$0.02+$0.01$0.02$45.44 million$33.62 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
N/AN/AN/AN/AN/A
Cronos Group Inc. stock logo
CRON
Cronos Group
N/AN/AN/AN/AN/A
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
N/AN/AN/AN/AN/A
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
41.22
2.00
2.67
Cronos Group Inc. stock logo
CRON
Cronos Group
N/A
27.80
26.75
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
7.52
3.36
1.79
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
0.12
2.62
1.61

Institutional Ownership

CompanyInstitutional Ownership
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
1.38%
Cronos Group Inc. stock logo
CRON
Cronos Group
8.71%
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
12.58%
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
9.35%

Insider Ownership

CompanyInsider Ownership
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
42.00%
Cronos Group Inc. stock logo
CRON
Cronos Group
7.30%
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
45.62%
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
0.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
517.95 millionN/ANot Optionable
Cronos Group Inc. stock logo
CRON
Cronos Group
450385.68 million357.53 millionOptionable
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
725101.15 millionN/ANot Optionable
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
2,6501.01 billion1.00 billionOptionable

Recent News About These Companies

Top Canadian Cannabis Picks for U.S. Market Expansion in 2025
Financial markets news icon
MarketBeat Week in Review – 07/14 - 07/18 (TLRY)
...
Tilray (TLRY) Stock Is Up, What You Need To Know
Tilray Brands (NASDAQ:TLRY) Shares Up 4% - What's Next?
Tilray Brands (NasdaqGS:TLRY) Soars 44% In Last Month
Cannabis Stocks To Follow Today - July 13th
Promising Cannabis Stocks To Follow Now - July 12th
Top Cannabis Stocks To Watch Today - July 11th

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Cipher Pharmaceuticals stock logo

Cipher Pharmaceuticals TSE:CPH

C$12.33 -0.58 (-4.49%)
As of 07/18/2025 04:00 PM Eastern

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company's geographical segments include Canada and the United States.

Cronos Group stock logo

Cronos Group NASDAQ:CRON

$2.01 -0.04 (-1.95%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$2.00 -0.01 (-0.75%)
As of 07/18/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

Knight Therapeutics stock logo

Knight Therapeutics TSE:GUD

C$6.05 -0.16 (-2.58%)
As of 07/18/2025 04:00 PM Eastern

Knight Therapeutics Inc. develops, manufactures, acquires, in-licenses, out-licenses, markets, and distributes pharmaceutical and consumer health products, and medical devices worldwide. It offers Tafasitamab for relapsed or refractory diffuse large B-cell lymphoma; Pemigatinib for metastatic cholangiocarcinoma; Akynzeo for prevention of chemotherapy-induced acute and delayed nausea and vomiting; Aloxi for prevention of acute nausea and vomiting associated with emetogenic cancer chemotherapy; Fostamatinib for chronic immune thrombocytopenia; Nerlynx for extended adjuvant breast cancer and metastatic breast cancer; Trelstar for advanced prostate cancer; Vidaza for myelodysplastic syndrome; Abraxane for metastatic pancreatic cancer; Halaven for metastatic breast cancer and soft tissue sarcoma; and Lenvima for advanced renal cell cancer and for differentiated thyroid cancer and unresectable hepatocellular carcinoma. The company provides Ladecvina for multiple myeloma and myelodysplastic syndrome, mantle cell lymphoma, and follicular lymphoma; Zyvalix for metastatic prostate cancer; Karfib for relapsed or refractory multiple myeloma; Leprid for advanced prostate cancer; Rembre for chronic myeloid leukemia; Palbocil for breast cancer; Ambisome and Cresemba for fungal infection; Impavido for leishmaniasis; Dolufevir for HIV infection; Exelon for dementia; and Ibsrela for irritable bowel syndrome with constipation. In addition, it offers Salofalk for ulcerative colitis; Ursofalk for biliary cirrhosis; Imvexxy for moderate to severe dyspareunia; Bijuva for vasomotor symptoms; Fibridoner for idiopathic pulmonary fibrosis; Toliscrin DPI for pseudomonas aeruginosa lung infection; Toliscrin 1-2 for severe acute or resistant chronic infections; and Tobradosa Haler for chronic lung infections. Further, it finances other life science companies; and invests in life sciences venture capital funds. The company was incorporated in 2013 and is headquartered in Montreal, Canada.

Tilray Brands stock logo

Tilray Brands NASDAQ:TLRY

$0.62 +0.01 (+1.64%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$0.63 +0.01 (+1.72%)
As of 07/18/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.